Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07786844

A Study on the Application of NE Irrigation Fluid for Hemostasis in Flexible Ureteroscopic Lithotripsy: A Prospective Single-arm Interventional Study of Upper Urinary Tract Calculi.(NE: Norepinephrine)

Urinary stone disease is globally prevalent with rising incidence and recurrence, imposing heavy socioeconomic burdens. Flexible ureteroscopy has advanced stone treatment. Single-use flexible ureteroscopes (su-fURS) combined with negative pressure ureteral access sheath (NPUAS), recommended by urology guidelines, improve surgical safety and stone-free rates and can treat stones ≤3 cm. However, su-fURS has poorer image quality, bleeding during lithotripsy may blur vision, frequently impairing efficiency and safety.

Norepinephrine (NE), a tyrosine-derived sympathomimetic amine, mainly activates α1 and β1 receptors. Doses above 3 μg/min trigger predominant α1-mediated vasoconstriction of arteries and veins. It can act on mucosal surfaces via irrigation fluid, making it favorable for initial hemostasis of injured mucosa. Firstly, this study aims to evaluate the efficacy and safety of low-concentration norepinephrine (NE) irrigation solution for hemostasis during lithotripsy performed with single-use flexible ureteroscope (su-fURS) combined with NPUAS, fifteen subjects will be enrolled in the study. Secondly, we explore the dose-effect relationships of four concentrations: 2 mg/3 L, 4 mg/3 L, 6 mg/3 L and 8 mg/3 L, and determine the optimal concentration by comprehensively evaluating hemostatic efficacy and safety. A total of 40 subjects will be enrolled, with 10 subjects in each concentration.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Geriatric Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210009, China

Location status: Recruiting

Location contact

Jing Zhao, PhD

CONTACT

[email protected]

+8615205197656

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-75 years of either sex.
  • Clinically and radiologically confirmed renal or upper-ureteral stone with operative indication for super flexible ureteroscopic lithotripsy combined with negative pressure ultrasound lithotripsy (su-fURS + NPUAS).
  • Subjects with definite surgical indication for upper urinary tract stones, tolerate general anesthesia, and agree to receive the targeted operative procedure.

Exclusion criteria

  • Diagnosis of non-upper urinary tract stones.
  • Intolerance to flexible ureteroscopic surgery.
  • Poorly-controlled hypertension with blood pressure greater than 160/100 mmHg.
  • History of coronary artery disease.

Treatment and study plan

Using irrigation fluid with a certain concentration of norepinephrine

Drug
  • Treat with 4 mg/3 L norepinephrine (NE) irrigation fluid during su-fURS combined with NPUAS lithotripsy.
  • Treat with different concentrations of norepinephrine irrigation fluid (2 mg/3 L, 4 mg/3 L, 6 mg/3 L, 8 mg/3 L) when lithotripsy.

Primary outcomes

  1. Hemoglobin concentration in irrigation fluid

    Time frame: Under identical operating conditions, the irrigation fluid was collected before and 3 minutes after treatment with 4 mg/3 L NE bitartrate irrigation fluid.

    Collect irrigation fluid samples before and after norepinephrine irrigation treatment, and measure the hemoglobin concentration in the irrigation fluid.

  2. Systolic blood pressure (SBP)

    Time frame: Periprocedural

    After treatment with NE irrigation fluid. Systolic blood pressure was obtained from anesthesia records.

  3. Mean arterial pressure (MAP)

    Time frame: Periprocedural

    After treatment with NE irrigation fluid. Mean arterial pressure (MAP) was obtained from anesthesia records

  4. Heart rate (HR)

    Time frame: Periprocedural

    After treatment with NE irrigation fluid. Heart rate (HR) was obtained from anesthesia records.

Secondary outcomes

  1. Safety-related discontinuation proportion (SRD)

    Time frame: From initiation of study intervention up to completion of surgical procedure (within-operative period)

    The proportion of participants whose study intervention is prematurely terminated because of safety-related adverse events or safety concerns.

  2. Concomitant medications(CMs)

    Time frame: From initiation of study intervention up to completion of surgical procedure (within-operative period)

    Record the type, dosage, route, and duration of all concomitant medications administered to participants during the study, including medications for underlying diseases, peri-operative supportive drugs and rescue medications.

  3. Incidence of adverse events(IAEs)

    Time frame: From time of initial intervention through 8 hours post-procedure, assessed up to Post-operative Day 1

    Incidence of all-cause adverse events occurring in participants after study, including peri-operative complications and post-operative adverse events.

  4. Stone clearance rate(SCR)

    Time frame: 1 day after surgical procedure

    Proportion of participants achieving stone-free status, defined as no residual stones or residual stone fragments ≤2 mm on postoperative imaging examination.

Study contacts

Contact information is provided by the study sponsor or research team.

Chuang Wu, Doctor of Medicine

CONTACT

[email protected]

+8618156836569

Sponsors and collaborators

Lead sponsor

Geriatric Hospital of Nanjing Medical University

Other

Registry information

Official study title

Hemostasis and Safety Analysis of Norepinephrine Irrigation Fluid in Su-FURS Combined With NPUAS Lithotripsy. (Su-FURS: Single-use Flexible Ureteroscope, NPUAS: Negative Pressure Ureteral Access Sheath)

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 26, 2026
Registry last updated
Aug 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.